Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The chemical chaperone trimethylamine N-oxide ameliorates the effects of mutant keratins in cultured cells.

× No keyword cloud information.

8 in total

1. Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods.

Authors: Richard J Nowak; Gregory D Cuny; Sungwoon Choi; Peter T Lansbury; Soumya S Ray
Journal: J Med Chem Date: 2010-04-08 Impact factor: 7.446

2. "Panta rhei": Perpetual cycling of the keratin cytoskeleton.

Authors: Rudolf E Leube; Marcin Moch; Anne Kölsch; Reinhard Windoffer
Journal: Bioarchitecture Date: 2011-01

3. Chemical chaperone therapy, a new strategy for genetic skin fragility disorders.

Authors: Jean Christopher Chamcheu; Imtiaz A Siddiqui; Hasan Mukhtar
Journal: Exp Dermatol Date: 2016-03 Impact factor: 3.960

4. Reducing the effects of intracellular accumulation of thermolabile collagen II mutants by increasing their thermostability in cell culture conditions.

Authors: Katarzyna Gawron; Deborah A Jensen; Andrzej Steplewski; Andrzej Fertala
Journal: Biochem Biophys Res Commun Date: 2010-04-13 Impact factor: 3.575

Review 5. Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Authors: Jean Christopher Chamcheu; Gary S Wood; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Joyce M Teng; Hasan Mukhtar
Journal: Exp Dermatol Date: 2012-07 Impact factor: 3.960

The chemical chaperone trimethylamine N-oxide ameliorates the effects of mutant keratins in cultured cells.

1. Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods.

2. "Panta rhei": Perpetual cycling of the keratin cytoskeleton.

3. Chemical chaperone therapy, a new strategy for genetic skin fragility disorders.

4. Reducing the effects of intracellular accumulation of thermolabile collagen II mutants by increasing their thermostability in cell culture conditions.

Review 5. Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Review 6. Cytoskeleton in motion: the dynamics of keratin intermediate filaments in epithelia.

Review 7. Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath.

Review 8. Emerging novel concept of chaperone therapies for protein misfolding diseases.